Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Total article views   Abstract views HTML views PDF downloads Totals
3,168 Dovepress* 2,577 308+ 298 2,885
PubMed Central* 0 283 127 283
Totals 2,577 591 425 3,168
*Since 24 September 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 6 6

View citations on PubMed Central and Google Scholar